FDA Inspection 1192631 — Bruce A. Segal, M.D.
The FDA completed an inspection of Bruce A. Segal, M.D. on November 29, 2022 in Delray Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 29, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Delray Beach, FL (United States)
Additional Details
Clinical Investigator (CI)